Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

NCT03971253 · clinicaltrials.gov ↗

RECRUITING

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: Peficitinib

Sponsor

Astellas Pharma Inc